American Society of Hematology

2019 Highlights of ASH® in North America

January 11-12, 2019
San Francisco, CA
Washington, DC
January 18-19, 2019
Chicago, IL
Seattle, WA
January 25-26, 2019
Dallas, TX
New York, NY

 

Join the world's leading hematology experts at Highlights of ASH in North America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Through participation in this meeting, you will be able to:

  • Recap stand-out abstracts from the most recent ASH annual meeting
  • Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field
  • Participate in interactive panel discussions and attend lunch with the experts
  • Improve therapeutic and overall practice methods
  • Discover new treatments for patients

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

Exposition

The 2018 Highlights of ASH in North America meetings featured an exhibition of products and services in the areas of hematology and blood transfusion. Participants in this exposition included the most renowned companies in the industry, including:

  • AbbVie, Inc.
  • Agios Pharmaceuticals
  • Alexion Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Amgen, Inc.
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals
  • BMS/Pfizer
  • Celgene Corporation
  • Genentech, Inc.
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Janssen Biotech, Inc.
  • Jazz Pharmaceuticals, Inc.
  • Kite Pharma, Inc.
  • Merck & Co.
  • Novartis Oncology
  • Pfizer Oncology
  • Pharmacyclics, An AbbVie Company
  • Seattle Genetics
  • Takeda Oncology
  • Tolero Pharmaceuticals

For information about sponsoring and/or exhibiting at Highlights of ASH, contact Thelma Barnett at corporatesupport@hematology.org.

Corporate Support

ASH thanks the following for their support of the 2018 Highlights of ASH in North America meetings:

  • Amgen, Inc.
  • Astellas Pharma
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals
  • Celgene Corporation
  • Genentech, Inc.
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Jazz Pharmaceuticals, Inc.
  • Merck & Co.
  • Novartis Oncology
  • Pfizer Oncology
  • Pharmacyclics, An AbbVie Company
  • Seattle Genetics

Mobile app brought to you by Agios Pharmaceuticals.

back to top